中国药房2015，Vol.26Issue(36)：5110-5113,4.DOI:10.6039/j.issn.1001-0408.2015.36.25
消渴丸对比格列本脲治疗2型糖尿病疗效与安全性的系统评价
Efficacy and Safety of Xiaoke Pill versus Glibenclamide in the Treatment of Type 2 Diabetes Mellitus:A Sys-tematic Review
摘要
Abstract
OBJECTIVE:To systematically review the efficacy and safety of Xiaoke pill versus glibenclamide in the treatment of type 2 diabetes mellitus,and provide evidence-based reference for clinical treatment. METHODS:Retrieved from Medline, PubMed,EMBase,Cochrane Library,CBM,CJFD,Wanfang Database and VIP Database,randomized controlled trials (RCT) about the Xiaoke pill(test group)versus glibenclamide(control group)in the treatment of type 2 diabetes mellitus were enrolled. Meta-analysis was performed by using Rev Man 5.2 software after document selection,data extract and quality assessment by Co-chrane systematical evaluation. RESULTS:A total of 15 RCT were included,involving 3 319 patients. Results of Meta-analysis showed the hemoglobin A1c (HbA1c) level [MD=-0.39,95%CI(-0.75,-0.02),P=0.04],fasting plasma glucose (FPG) level [MD=-0.70,95%CI(-1.27,-0.12),P=0.02],2 h PG[MD=-0.87,95%CI(-1.55,-0.20),P=0.01],incidence of thirst with desire for drinks [RR=3.35,95%CI(1.92,5.85),P<0.001],incidence of tiredness and debilitation[RR=5.74,95%CI(3.52, 9.36),P<0.001] and incidence of hypoglycemia [RR=0.67,95%CI(0.49,0.91),P=0.01] in test group were significantly lower than control group,the differences were statistically significant. CONCLUSIONS:Xiaoke pill has better efficacy and safety than glibenclamide in the treatment of type 2 diabetes mellitus,can obviously improve the HbA1c,FPG,2 h PG tevel and TCM symp-toms.关键词
消渴丸/格列本脲/2型糖尿病/疗效/安全性/系统评价Key words
Xiaoke pill/Glibenclamide/Type 2 diabetes mellitus/Efficacy/Safety/Systematic review分类
医药卫生引用本文复制引用
汪永忠,李颖,李翔,罗欢,姜辉,李影..消渴丸对比格列本脲治疗2型糖尿病疗效与安全性的系统评价[J].中国药房,2015,26(36):5110-5113,4.基金项目
国家科技支撑计划课题(No.2013BAI06B04) （No.2013BAI06B04）
